Investor Presentaiton

Non-oncology Pipeline Summary: 5 Assets in Pipeline under Development (1 product launched, 4 assets in clinical trials) Non-oncology Pipeline One-carbon metabolism + IBI-362 (GLP1/GCGR) IBI-306 (PCSK9) Innovent TNF-a IL-6 FGF21 + Carbohydrate Fat, protein 4 Liver fat DNL B-oxi Streptococcus Folate DIA/Obesity/NASH CARDIOVASCULAR OPHTHALMOLOGY AUTO-IMMUNE Confidential Copyright©2021 Innovent Biologics IBI-302 (VEGF/Complement) IBI-303 (TNF-α) IBI-112 (IL-23 p19) 16

View entire presentation